MCAD deficiency: Difference between revisions
From WikiLectures
No edit summary |
m (checked by the editor) |
||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
'''Medium chain | '''Medium-chain acyl-coenzyme A dehydrogenase A deficiency''' (medium-chain acyl-coenzyme A dehydrogenase, MCAD) is a relatively common inherited metabolic disorder of mitochondrial fatty acid β-oxidation metabolism. The incidence in the UK and US is '''1: 10,000'''. | ||
== Clinical signs == | == Clinical signs == | ||
Latest revision as of 17:41, 9 April 2022
Medium-chain acyl-coenzyme A dehydrogenase A deficiency (medium-chain acyl-coenzyme A dehydrogenase, MCAD) is a relatively common inherited metabolic disorder of mitochondrial fatty acid β-oxidation metabolism. The incidence in the UK and US is 1: 10,000.
Clinical signs[edit | edit source]
Life-threatening hypoglycemia occurs during starvation, and infections are also common. The disease manifests itself in infancy, with a positive prognosis for survival into old age.
Therapy[edit | edit source]
The treatment of MCAD deficiency consists in:
- starvation prevention;
- corn starch nutrition;
- parenteral nutrition must be instituted in lethargy and vomiting leading to coma (differential diagnostic attention to Reye's syndrome).
Links[edit | edit source]
Related articles[edit | edit source]
References[edit | edit source]
- Hřebíček, Martin: Dědičné poruchy metabolismu mitochondrií. [přednáška z patobiochemie], 12. 10. 2010
- FERNANDES, John, Jean-Marie SAUDUBRAY a Georges van den BERGHE, et al. Diagnostika a léčba dědičných metabolických poruch. 4. vydání. Praha : Triton, 2008. 607 s. ISBN 978-80-7387-096-6.
